Leopard syndrome

Jump to navigation Jump to search
LEOPARD syndrome
21 month old, third generation patient, confirmed by genetic tests as Y279C, exhibiting ocular hyperteliorism, cephalofacial similarity.
OMIM 151100
DiseasesDB 7387
eMedicine derm/627 
MeSH C05.660.207.525

WikiDoc Resources for Leopard syndrome

Articles

Most recent articles on Leopard syndrome

Most cited articles on Leopard syndrome

Review articles on Leopard syndrome

Articles on Leopard syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Leopard syndrome

Images of Leopard syndrome

Photos of Leopard syndrome

Podcasts & MP3s on Leopard syndrome

Videos on Leopard syndrome

Evidence Based Medicine

Cochrane Collaboration on Leopard syndrome

Bandolier on Leopard syndrome

TRIP on Leopard syndrome

Clinical Trials

Ongoing Trials on Leopard syndrome at Clinical Trials.gov

Trial results on Leopard syndrome

Clinical Trials on Leopard syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Leopard syndrome

NICE Guidance on Leopard syndrome

NHS PRODIGY Guidance

FDA on Leopard syndrome

CDC on Leopard syndrome

Books

Books on Leopard syndrome

News

Leopard syndrome in the news

Be alerted to news on Leopard syndrome

News trends on Leopard syndrome

Commentary

Blogs on Leopard syndrome

Definitions

Definitions of Leopard syndrome

Patient Resources / Community

Patient resources on Leopard syndrome

Discussion groups on Leopard syndrome

Patient Handouts on Leopard syndrome

Directions to Hospitals Treating Leopard syndrome

Risk calculators and risk factors for Leopard syndrome

Healthcare Provider Resources

Symptoms of Leopard syndrome

Causes & Risk Factors for Leopard syndrome

Diagnostic studies for Leopard syndrome

Treatment of Leopard syndrome

Continuing Medical Education (CME)

CME Programs on Leopard syndrome

International

Leopard syndrome en Espanol

Leopard syndrome en Francais

Business

Leopard syndrome in the Marketplace

Patents on Leopard syndrome

Experimental / Informatics

List of terms related to Leopard syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

LEOPARD syndrome is a rare autosomal dominant,[1] multisystem disease caused by a mutation in the protein tyrosine phosphatase, non-receptor type 11 gene (PTPN11). The disease is a complex of features, mostly involving the skin, skeletal and cardiovascular systems, they may or may not be present in all patients. The nature of how the mutation causes each of the condition's symptoms is not well known, however research is ongoing. Related to Noonan syndrome, LEOPARD syndrome is caused by a different missense mutation of the same gene. LEOPARD syndrome may also be called multiple lentigines syndrome, cardiomyopathic lentiginosis, Gorlin's syndrome II, Capute-Rimoin-Konigsmark-Esterly-Richardson syndrome, or Moynahan syndrome. Noonan syndrome is fairly common (1:1000 to 1:2500 live births), and neurofibromatosis 1 (which was once thought to be related to LEOPARD syndrome) is also common (1:3500), but however no epidemiologic data exists for LEOPARD syndrome.[2]

Signs and symptoms

The name of the condition is a mnemonic, originally coined in 1969,[3] as the condition is characterized by some of the following seven conditions, the first letters of which spell LEOPARD, along with the characteristic "freckling" of the skin, caused by the lentigines that is reminiscent of the large cat.

The presence of all of these hallmarks is not needed for a diagnosis. A clinical diagnosis is considered made when, with lentigines present there are 2 other symptoms observed, such as ECG abnormalities and ocular hypertelorism, or without lentigines, 3 of the above conditions are present, with a first-degree relative (i.e. parent, child, sibling) with a clinical diagnosis.[4]

  • additional dermatologic abnormalities (axillary freckling, localized hypopigmentation, interdigital webbing, hyperelastic skin)
  • Mild mental retardation is observed in about 30% of those affected with the syndrome
  • Nystagmus (involuntary eye movements), seizures, or hyposmia (reduced ability to smell) has been documented in a few patients
  • In 2004, a patient was reported with recurrent upper extremity aneurysms that required surgical repairs.[5]
  • In 2006, a LEOPARD syndrome patient was reported with acute myelogenous leukemia.[6]

Unfortunately, due to the rarity of the syndrome itself, it is hard to determine whether certain additional diseases are actually a threat of the syndrome. With a base population of possibly less than one thousand individuals, one or two outlying cases can skew the statistical population very quickly.

Diagnosis

The presence of the disease can be confirmed with a genetic test. In a study of 10 infants with clinical indications of LEOPARD syndrome prior to their first birthday, 8 (80%) patients were confirmed to have the suspected mutation. An additional patient, with the suspected mutation was subsequently found to have NF1, following evaluation of the mother.[7]

There are 5 identified allelic variants responsible for LEOPARD syndrome. Y279C, T468M, A461T, G464A, and Q510P which seems to be a unique familial mutation, in that all other variants are caused by transition errors, rather than transversion.

Pathophysiology

In the two predominant mutations of LEOPARD syndrome (Y279C and T468M) the mutations cause a loss of catalytic activity of the SHP2 protein(the gene product of the PTPN11 gene), which is a previously unrecognized behavior for this class of mutations.[8] This interferes with growth factor and related signalling. While further research confirms this mechanism,[9][10] additional research is needed to determine how this relates to all of the observed effects of LEOPARD syndrome.

Prognosis and treatment

In itself, LEOPARD syndrome is not a life threatening diagnosis, most people diagnosed with the condition live normal lives. Obstructive cardiomyopathy and other pathologic findings involving the cardiovascular system may be a cause of death in those whose cardiac deformities are profound.

It is suggested that, once diagnosed, individuals be routinely followed by a cardiologist, endocrinologist, dermatologist, and other appropriate specialties as symptoms present.

It is recommended that those with the syndrome who are capable of having children seek genetic counseling before deciding to have children. As the syndrome presents frequently as a forme fruste (incomplete, or unusual form) variant, an examination of all family members must be undertaken.[11] As an autosomal dominant trait there is a fifty percent chance with each child, that they will also be born with the syndrome. This does not take into account the possibility of the gene mutating, on its own, in a child of a LEOPARD syndrome patient who does not inherit the gene from the affected parent. Since the syndrome has a variable penetrance and expression, one generation may have a mild expression of the syndrome, while the next may be profoundly affected.

Once a decision to have children is made, and the couple conceives, the fetus is monitored during the pregnancy for cardiac evaluation. If a gross cardiac malformation is found, parents receive counseling on continuing with the pregnancy.

Other management is routine care as symptoms present:[11]

  1. For those with endocrine issues (low levels of thyrotopin [a pituitary hormone responsible for regulating thyroid hormones], follicle stimulating hormone) drug therapy is recommended.
  2. For those who are disturbed by the appearance of lentigines, cryosurgery may be beneficial. Due to the large number of lentigines this may prove time consuming. An alternative treatment with tretinoin or hydroquinone creams may help.
  3. Drug therapies for those with cardiac abnormalities, as those abnormalities become severe enough to warrant the use of these therapies. ECG's are mandatory prior to any surgical interventions, due to possible arrythmia.

Epidemiology

Various literature describes it as being "rare"[11] or "extremely rare".[12] There is no epidemiologic data available, regarding how many in the world population suffer from the syndrome, however there are slightly over 100 cases described in medical literature.

History

Zeisler and Becker first described a syndrome with multiple lentigines, hypertelorism, pectus carinatum (protruding breastbone) and prognathism (protrusion of lower jaw) in 1936.[13] Sporadic descriptions were added through the years. In 1962, cardiac abnormalities and short stature were first associated with the condition.[14] In 1966, three familial cases were added, a mother, her son and daughter.[15] Another case of mother to two separate children, with different paternity of the two children, was added in 1968.[16]

It was believed as late as 2002[17] that LEOPARD syndrome was related to neurofibromatosis type I (von Recklinghausen syndrome). In fact, since both ICD9 and ICD10 lack a specific diagnosis code for LEOPARD syndrome, the diagnosis code for NF1 is still sometimes used for diagnostic purposes, although it has been shown that the gene is not linked to the NF1 locus.[18]

See also

References

  1. Coppin BD, Temple IK (1997). "Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis)". J. Med. Genet. 34 (7): 582–6. PMID 9222968.
  2. Tullu MS, Muranjan MN, Kantharia VC; et al. (2000). "Neurofibromatosis-Noonan syndrome or LEOPARD Syndrome? A clinical dilemma". J Postgrad Med. 46 (2): 98–100. PMID 11013475.
  3. Gorlin RJ, Anderson RC, Blaw M (1969). "Multiple lentigenes syndrome". Am. J. Dis. Child. 117 (6): 652–62. PMID 5771505.
  4. Voron DA, Hatfield HH, Kalkhoff RK (1976). "Multiple lentigines syndrome. Case report and review of the literature". Am. J. Med. 60 (3): 447–56. PMID 1258892.
  5. Yagubyan M, Panneton JM, Lindor NM, Conti E, Sarkozy A, Pizzuti A (2004). "LEOPARD syndrome: a new polyaneurysm association and an update on the molecular genetics of the disease". J. Vasc. Surg. 39 (4): 897–900. doi:10.1016/j.jvs.2003.11.030. PMID 15071461. Unknown parameter |month= ignored (help)
  6. Uçar C, Calýskan U, Martini S, Heinritz W (2006). "Acute myelomonocytic leukemia in a boy with LEOPARD syndrome (PTPN11 gene mutation positive)". J. Pediatr. Hematol. Oncol. 28 (3): 123–5. doi:10.1097/01.mph.0000199590.21797.0b. PMID 16679933. Unknown parameter |month= ignored (help)
  7. Digilio MC, Sarkozy A, de Zorzi A; et al. (2006). "LEOPARD syndrome: clinical diagnosis in the first year of life". Am. J. Med. Genet. A. 140 (7): 740–6. doi:10.1002/ajmg.a.31156. PMID 16523510.
  8. Tartaglia M, Martinelli S, Stella L; et al. (2006). "Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease". Am. J. Hum. Genet. 78 (2): 279–90. doi:10.1086/499925. PMID 16358218.
  9. Hanna N, Montagner A, Lee WH; et al. (2006). "Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1". FEBS Lett. 580 (10): 2477–82. doi:10.1016/j.febslet.2006.03.088. PMID 16638574.
  10. Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG (2006). "PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects". J. Biol. Chem. 281 (10): 6785–92. doi:10.1074/jbc.M513068200. PMID 16377799.
  11. 11.0 11.1 11.2 Sergiusz Jozwiak, MD, PhD. "eMedicine - LEOPARD Syndrome". Retrieved 2008-01-20.
  12. "NORD - National Organization for Rare Disorders, Inc". Retrieved 2008-01-20.
  13. Zeisler EP, Becker SW (1936). "Generalized lentigo: its relation to systemic nonelevated nevi". Arch Dermatol Syphilol. 33: 109–125.
  14. Moynahan EJ (1962). "Multiple symmetrical moles, with psychic and somatic infantilism and genital hypoplasia: first male case of a new syndrome". Proc Roy Soc Med. 55: 959–960. PMC 1896920
  15. Walther RJ, Polansky BJ, Grotis IA (1966). "Electrocardiographic abnormalities in a family with generalized lentigo". N. Engl. J. Med. 275 (22): 1220–5. PMID 5921856.
  16. Matthews NL (1968). "Lentigo and electrocardiographic changes". N. Engl. J. Med. 278 (14): 780–1. PMID 5638719.
  17. National Library of Medicine MeSH: C05.660.207.525
  18. Ahlbom BE, Dahl N, Zetterqvist P, Annerén G (1995). "Noonan syndrome with café-au-lait spots and multiple lentigines syndrome are not linked to the neurofibromatosis type 1 locus". Clin. Genet. 48 (2): 85–9. PMID 7586657.

External links

de:LEOPARD-Syndrom

Template:WH Template:WS Template:Jb1